万方数据万方数据万方数据万方数据提高进展期(巴塞罗那分期C期)肝细胞癌疗效的有效途径作者：程树群， 卫旭彪， 吴孟超， Cheng Shuqun， Wei Xubiao， Wu Mengchao作者单位：第二军医大学附属东方肝胆外科医院, 上海,200433刊名：中华外科杂志英文刊名：Chinese Journal of Surgery年，卷(期)：2015,53(5)1.Jemal A;Bray F;Center MM Global cancer statistics 2011(2)2.Wingo PA;Tong T;Bolden S Cancer statistics,1995 1995(1)3.European Association For The Study Of The Liver;European Organisation For Research And Treatment Of Cancer EASLEORTC clinical practice guidelines:management of hepatocellular carcinoma 2012(4)4.中华人民共和国卫生部原发性肝癌诊疗规范(2011年版) 2011(11)5.Shuqun C;Mengchao W;Han C Tumor thrombus types influence the prognosis of hepatocellular carcinoma with the tumor thrombi in the portal vein 2007(74)6.Lin DX;Zhang QY;Li X An aggressive approach leads to improved survival in hepatocellular carcinoma patients with portal vein tumor thrombus 2011(1)7.Yu YQ;Xu DB;Zhou XD Experience with liver resection after hepatic arterial chemoembolization for hepatocellular carcinoma 1993(1)8.Shi J;Lai EC;Li N A new classification for hepatocellular carcinoma with portal vein tumor thrombus 2011(1)9.Shi J;Lai EC;Li N Surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus 2010(8)10.Fujino H;Kimura T;Aikata H Role of 3-D conformal radiotherapy for major portal vein tumor thrombosis combined with hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma 201411.Tang QH;Li A J;Yang GM Surgical resection versus conformal radiotherapy combined with TACE for resectable hepatocellular carcinoma with portal vein tumor thrombus:a comparative study 2013(6)12.Zheng JS;Long J;Sun B Transcatheter arterial chemoembolization combined with radiofrequency ablation can improve survival of patients with hepatocellular carcinoma with portal vein tumour thrombosis:extending the indication for ablation 2014(6)13.Naugler WE;Alsina AE;Frenette CT Building the multidisciplinary team for management of patients With hepatocellular carcinoma 201414.Yang P;Li QJ;Feng Y TGF-beta-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma 2012(3)15.Huang G;Lai EC;Lau WY Posthepatectomy HBV reactivation in hepatitis B-related hepatocellular carcinoma influences postoperative survival in patients with preoperative low HBV-DNA levels 2013(3)16.Li N;Lai EC;Shi J A comparative study of antiviral therapy after resection of hepatocellular carcinoma in the immune-active phase of hepatitis B virus infection 2010(1)17.Yin J;Li N;Han Y Effect of antiviral treatment with nucleotide/nucleoside analogs on postoperative prognosis of hepatitis B virus-related hepatocellular carcinoma:a two-stage longitudinal clinical study 2013(29)18.Llovet JM;Ricci S;Mazzaferro V Sorafenib in advanced hepatocellular carcinoma 2008(4)19.Cheng AL;Kang YK;Chen Z Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma:a phase Ⅲ randomised,double-blind,placebo-controlled trial 2009(1)20.Irtan S;Chopin-Laly X;Ronot M Complete regression of locally advanced hepatocellular carcinoma induced by sorafenib allowing curative resection 2011(5)21.Wang SX;Byrnes A;Verma S Complete remission of unresectable hepatocellular carcinoma treated with reduced dose of sorafenib:a case report 2010(1)22.Zhao Y;Wang WJ;Guan S Sorafenib combined with transarterial chemoembolization for the treatment of advanced hepatocellular carcinoma:a large-scale multicenter study of 222patients 2013(7)23.Lee JE;Bae SH;Choi JY Epirubicin,cisplatin,5-FU combination chemotherapy in sorafenib-refractory metastatic hepatocellular carcinoma 2014(1)24.Petrini I;Lencioni M;Ricasoli M Phase Ⅱ trial of sorafenib in combination with 5-fluorouracil infusion in advanced hepatocellular carcinoma 2012(3)25.Feng YX;Wang T;Deng YZ Sorafenib suppresses postsurgical recurrence and metastasis of hepatocellular carcinoma in an orthotopic mouse model 2011(2)26.Qin S;Bai Y;Lim HY Randomized,multicenter,open-label study of oxaliplatin plus fluorouracil/leucovorin versus doxorubicin as palliative chemotherapy in patients with advanced hepatocellular carcinoma from Asia 2013(28)27.Zaanan A;Williet N;Hebbar M Gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma:a large multicenter AGEO study 2013(1)28.Zhang Y;Guan DX;Shi J All-trans retinoic acid potentiates the chemotherapeutic effect of cisplatin by inducing differentiation of tumor initiating cells in liver cancer 2013(6)引用本文格式：程树群.卫旭彪.吴孟超.Cheng Shuqun.Wei Xubiao.Wu Mengchao提高进展期(巴塞罗那分期C期)肝细胞癌疗效的有效途径[期刊论文]-中华外科杂志 2015(5)。